Literature DB >> 25073003

Prostate cancer: is androgen-deprivation therapy chosen wisely?

M Teresa Villanueva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25073003     DOI: 10.1038/nrclinonc.2014.130

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.

Authors:  Grace L Lu-Yao; Peter C Albertsen; Dirk F Moore; Weichung Shih; Yong Lin; Robert S DiPaola; Siu-Long Yao
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.